NCT01962337View on ClinicalTrials.gov

Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
HealthyRheumatoid Arthritis
Interventions
DRUG

FPA008

Infusion

DRUG

Placebo

Infusion

Trial Locations (6)

Unknown

BIK-Betegápoló Irgalmas rend-Budai Irgalmasrendi Kórház/Polyclinic of the Hospitaller Brothers of St. John of God in Budapest, Budapest

PRA Clinical Unit, Budapest

Drug Research Center, Kaposvár

PRA Early Development Services, Groningen

Oddział Kliniczny Kliniki Chorób Wewnętrznych Szpitala Uniwersyteckiego w Krakowie, Krakow

MedPolina, Poznan

Sponsors
All Listed Sponsors
lead

Five Prime Therapeutics, Inc.

INDUSTRY

NCT01962337 - Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects | Biotech Hunter | Biotech Hunter